These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7421962)

  • 1. An immunoglobulin (IgG) inhibitor of polymorphonuclear leukocyte motility in a patient with recurrent infection.
    Kramer N; Perez HD; Goldstein IM
    N Engl J Med; 1980 Nov; 303(22):1253-8. PubMed ID: 7421962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A specific inhibitor of complement (C5)-derived chemotactic activity in serum from patients with systemic lupus erythematosus.
    Perez HD; Lipton M; Goldstein IM
    J Clin Invest; 1978 Jul; 62(1):29-38. PubMed ID: 659635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotactic responsiveness and random motility of polymorphonuclear leukocytes from patients with progressive systemic sclerosis.
    Minta JO; Kovacs EK; Sukenik S; Lee P
    J Rheumatol; 1985 Dec; 12(6):1125-8. PubMed ID: 4093918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extensive botryomycosis in a patient with diabetes and chronic active hepatitis.
    Leibowitz MR; Asvat MS; Kalla AA; Wing G
    Arch Dermatol; 1981 Nov; 117(11):739-42. PubMed ID: 7316536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotactic function of polymorphonuclear leukocytes from patients with recurrent infections: partial correction by levamisole "in vitro".
    Stein AN; Díez RA; Sen L; Estévez ME
    Allergol Immunopathol (Madr); 1985; 13(2):127-34. PubMed ID: 4003229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independent effects of IgG and complement upon human polymorphonuclear leukocyte function.
    Goldstein IM; Kaplan HB; Radin A; Frosch M
    J Immunol; 1976 Oct; 117(4):1282-7. PubMed ID: 185296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wheat germ agglutinin specifically inhibits formyl peptide-induced polymorphonuclear leukocyte chemotaxis.
    Perez HD; Ong R; Khanna K; Banda D; Goldstein IM
    J Immunol; 1982 Dec; 129(6):2718-24. PubMed ID: 6897258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro phagocytosis of Candida albicans by peripheral polymorphonuclear neutrophils of patients with recurrent infections:Case reports of serum-dependent abnormalities.
    Verhaegen H; de Cock W; de Cree J
    Biomedicine; 1976 Jun; 24(3):164-70. PubMed ID: 136278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new defect of neutrophil chemotaxis and random motility in a child with recurrent bacterial infections and hyperimmunoglobulinemia E.
    Gahr M; Ranti J; Schröter W
    Eur J Pediatr; 1978 Mar; 127(3):173-9. PubMed ID: 648539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrinsic polymorphonuclear chemotactic defect in a boy with chronic granulomatous disease.
    de la Cruz R; Jain M; Hsu K; Lim DT
    Allergol Immunopathol (Madr); 1983; 11(6):457-64. PubMed ID: 6670661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonpurulent response to toxic shock syndrome toxin 1-producing Staphylococcus aureus. Relationship to toxin-stimulated production of tumor necrosis factor.
    Fast DJ; Schlievert PM; Nelson RD
    J Immunol; 1988 Feb; 140(3):949-53. PubMed ID: 3339245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of leucocyte chemokinesis and chemotaxis by human IgA.
    Kemp AS; Cripps AW; Brown S
    Clin Exp Immunol; 1980 May; 40(2):388-95. PubMed ID: 7438544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgG inhibitor of polymorphonuclear-leukocyte motility.
    Maderazo EG; Woronick CL
    N Engl J Med; 1981 Apr; 304(18):1109. PubMed ID: 6970896
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chemotaxis and phagocytosis of polymorphonuclear leukocytes in malnourished children].
    González-Mendoza A; Ramos-Zepeda R; Farinatti G; Urbiola MG; Frenk S
    Arch Invest Med (Mex); 1977; 8(3):175-84. PubMed ID: 411442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Polymorphonuclear leukocytes in dermatology. Physiology. Study methodology. Therapeutic applications].
    Stalder JF
    Ann Dermatol Venereol; 1984; 111(12):1109-24. PubMed ID: 6397089
    [No Abstract]   [Full Text] [Related]  

  • 16. Complement C4-derived monocyte-directed chemotaxis-inhibitory factor. A molecular mechanism to cause polymorphonuclear leukocyte-predominant infiltration in rheumatoid arthritis synovial cavities.
    Matsubara S; Yamamoto T; Tsuruta T; Takagi K; Kambara T
    Am J Pathol; 1991 May; 138(5):1279-91. PubMed ID: 2024711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The roles of IgG, IgM rheumatoid factor, and their complexes in the induction of polymorphonuclear leukocyte chemotactic factor from complement.
    Wagner T; Abraham G; Baum J
    J Clin Invest; 1974 Jun; 53(6):1503-11. PubMed ID: 4133792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement and immunoglobulins stimulate superoxide production by human leukocytes independently of phagocytosis.
    Goldstein IM; Roos D; Kaplan HB; Weissmann G
    J Clin Invest; 1975 Nov; 56(5):1155-63. PubMed ID: 171281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of polymorphonuclear neutrophils with Escherichia coli. Effect of enterotoxin on phagocytosis, killing, chemotaxis, and cyclic AMP.
    Bergman MJ; Guerrant RL; Murad F; Richardson SH; Weaver D; Mandell GL
    J Clin Invest; 1978 Feb; 61(2):227-34. PubMed ID: 202610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SGP140: identification of a novel component on human polymorphonuclear leukocyte cell surface involved in chemotactic and phagocytic activities.
    Yamamoto Y; Yamaguchi T; Sato K; Nishikawa Y; Hiragun A
    Exp Hematol; 1988 Jan; 16(1):12-20. PubMed ID: 2826199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.